Continuous Glucose Monitoring for Type 2 Diabetes in Pregnancy
CGM for Management of Type 2 Diabetes in Pregnancy
Recruiting
N/A
Interventional Study
Type 2 Diabetes Mellitus (T2DM)
Pregnancy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 50
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 564 (estimated)
- Sponsor
- University of Alabama at Birmingham · Other
Who this trial is looking for
This trial is looking for pregnant women with type 2 diabetes to see if using a continuous glucose monitor is better than checking blood sugar with fingersticks. Participants will monitor their blood sugar, complete surveys, and provide blood samples during the trial.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with type 2 diabetes.
- I am pregnant with a viable fetus between 6 to less than 23 weeks.
- I am between 18 and 50 years old.
- I take daily insulin injections or oral diabetes medications.
- My hemoglobin A1c is 6.5% or greater.
You may not be able to join if
- I cannot wear a continuous glucose monitor due to skin problems.
- I am having twins or more.
- My fetus has a major anomaly or multiple minor anomalies.
- I plan to deliver outside of the study area.
- I am already in another conflicting study.
- I participated in this trial before.
- I am unable to give my consent.
- My doctor has advised against my participation.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn if continuous glucose monitoring works better than self-monitoring of blood glucose (fingersticks) to treat type 2 diabetes in pregnancy. It will also learn about all risk factors (biologic, personal, social) for maternal and infant complications in type 2 diabetes pregnancies. The main questions it aims to answer are:
1. Does continuous glucose monitor…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Type 2 diabetes mellitus treated with daily insulin injections or oral hypoglycemic agents diagnosed before pregnancy or at less than 14 weeks gestation with hemoglobin A1c 6.5% or greater
* Pregnant with viable fetus at 6 to less than 23 weeks gestation
* Maternal age 18-50 y…
Contacts